Injectable ossotide's efficacy in treating condylar fractures
Keywords:
Ossotide for injection, numerical rating scale score,, condylar fracture,, interleukin, proteinAbstract
This research aimed to assess the impact of osteopeptide injections as a supplemental therapy for
condylar fractures on bone glycoprotein (BGP) and interleukin-1α (IL-1в) levels as well as pain
management.
Two groups of eighty-two condylar neck fracture patients were randomly assigned. The
experimental group received osteopeptide injections in addition to routine surgical treatments for
the control group. At 1, 2, and 4 weeks after surgery, the levels of pain, IL-1, and BGP were measured.
TWO WEEKS POST-SURGERY: On the Numerical Rating Scale, the experimental group fared better
than the control group. At all three evaluation periods (1, 2, and 4 weeks postsurgery), the control
group had higher BGP levels and lower IL-1 levels, whereas patients who received osteopeptide
injections had higher BGP levels and statistically significant differences (P < 0.05) in both.
CONCLUSIONS: After getting osteopeptide injections as an adjuvant therapy for condylar fractures,
patients may have less discomfort and begin exercising their muscles more quickly. Another
advantage of lowering inflammatory markers and boosting active osteogenesis is faster wound
healing.
